Point72 Asset Management
PNT

Point72 Asset Management’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Point72 Asset Management’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-789,100
Closed -$5.26M – 3003
2023
Q3 		$5.26M Sell
789,100
-1,140,067
-59% -$9.48M 0.02% 863
2023
Q2 		$17.5M Sell
1,929,167
-1,185,194
-38% -$10.5M 0.05% 423
2023
Q1 		$22.6M Sell
3,114,361
-83,204
-3% -$617K 0.07% 320
2022
Q4 		$23.3M Sell
3,197,565
-495,055
-13% -$3.67M 0.08% 305
2022
Q3 		$28.5M Buy
3,692,620
+1,738,391
+89% +$14.8M 0.11% 238
2022
Q2 		$13.3M Buy
1,954,229
+1,911,961
+4,523% +$14.6M 0.06% 431
2022
Q1 		$337K Buy
+42,268
New +$268K ﹤0.01% 1042
2021
Q2 		– Sell
-375,000
Closed -$3.94M – 1220
2021
Q1 		$3.94M Buy
+375,000
New +$5.09M 0.02% 620

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Point72 Asset Management's PNT Position: Q4 2023 in Review

Point72 Asset Management sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 789,100 shares — an estimated $5.26M sold.

Point72 Asset Management first reported a position in PNT in Q1 2021 and held it in 8 quarters. The position peaked at $28.5M in Q3 2022. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • Point72 Asset Management reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Point72 Asset Management sold 789,100 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $5.26M.
  • Point72 Asset Management first reported a position in POINT Biopharma Global Inc. Common Stock in Q1 2021 and held it in 8 quarters.
  • Point72 Asset Management's POINT Biopharma Global Inc. Common Stock position peaked at $28.5M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Point72 Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.